Login / Signup

The Hologic Aptima SARS-CoV-2 assay enables high ratio pooling saving reagents and improving turnaround time.

Kimberly NewsomYuan ZhangSrikar ChamalaKatherine MartinezMichael Clare-SalzlerPetr Starostik
Published in: Journal of clinical laboratory analysis (2021)
Performing pooled testing, one should monitor the weak positives with kRLU lower than 1012 or quantification cycle (Cq) value higher than 35 on an ongoing basis and adjust pooling approaches to avoid reporting false negatives.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • high throughput
  • adverse drug
  • randomized controlled trial
  • clinical trial
  • open label